Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis
about
Advances in proteomic study of cardiac amyloidosis: progress and potential.Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac responseNews in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.Prognosis and risk assessment in AL amyloidosis - There and back again.Rapid hematological responses improve outcomes in patients with very advanced (Stage IIIb) cardiac immunoglobulin light chain amyloidosis.Light Chain Amyloidosis.The six-minute walk test in patients with AL amyloidosis: a single centre case series.
P2860
Q38809423-6E8D2763-A0A9-40B4-98F7-147C7AEFC935Q39217713-5D16CE17-4716-44EF-8932-DB55FB812276Q39272596-DE150B6A-7741-4D93-B8DE-C05BB8E2FE18Q39446111-D4329AC6-C586-4F6A-9A82-99A28F9570B3Q46194651-726394A5-C85D-4B25-9978-45E79D7B489EQ48239985-E5D61DAA-D5A6-4C11-BD37-0437280811FDQ50158376-F16AB45D-D3D8-49D6-8CAF-B22FD50FA2D8Q52659305-8AB92723-7ED5-48A5-BB2A-D20560CDFEE5Q53402595-DF3A3F4D-F814-4865-A263-2FE1A6F602E0
P2860
Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Rationale, application and cli ...... n patients with AL amyloidosis
@ast
Rationale, application and cli ...... n patients with AL amyloidosis
@en
Rationale, application and cli ...... n patients with AL amyloidosis
@nl
type
label
Rationale, application and cli ...... n patients with AL amyloidosis
@ast
Rationale, application and cli ...... n patients with AL amyloidosis
@en
Rationale, application and cli ...... n patients with AL amyloidosis
@nl
prefLabel
Rationale, application and cli ...... n patients with AL amyloidosis
@ast
Rationale, application and cli ...... n patients with AL amyloidosis
@en
Rationale, application and cli ...... n patients with AL amyloidosis
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Rationale, application and cli ...... n patients with AL amyloidosis
@en
P2093
A Wechalekar
M S Maurer
R L Comenzo
V Sanchorawala
Yukio Ando
P2860
P2888
P304
P3181
P356
10.1038/LEU.2016.191
P407
P5008
P577
2016-07-15T00:00:00Z
P6179
1012665169